
Joanne Billings
, Associate Vice President for Research Integrity and Compliance · University of Minnesota
Credentials: · · · · · ·
History
- Present
- 1995–1998
Pulmonary Disease and Critical Care Medicine
- 1992–1995
Internal Medicine
- 1988–1992
Research
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
New England Journal of Medicine · 2021 · 1,404 citations
Pediatric Diabetes · 2013 · 166 citations
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
Thorax · 2013 · 165 citations
- JD
11 papers

4 papers

3 papers

3 papers

2 papers

2 papers

2 papers

2 papers
Grants
- 2003–2009
GCRC-General Clinical Research Center
National Center for Research Resources · M01
Project lead · $267.2K · University of Minnesota
- 2001–2008
Women's Health in Cystic Fibrosis
National Heart, Lung, and Blood Institute · K23
Contact PI · $708.5K · University of Minnesota
Clinical trials
- 2012–2015
Principal investigator · Unknown
Foundation for the National Institutes of Health
- 2006
A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
Principal investigator · Terminated · Phase 1
University of Minnesota
- 2006–2007
Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
Study director · Completed · Phase 1
Emphycorp
- 2024–2031


